The scientific foundation for decisions over whether patients benefit from having implants placed at the time of craniofacial ablative tumour surgery, or by delaying, seems rather weak. The authors of this systematic review do not provide any clear guidance in any direction, since there is apparently little or no evidence to support
The majority of papers reporting on clinical studies of maxillofacial reconstructions using dental implants following ablative tumour surgery describe treatment protocols where implants are not placed at the time of surgery. Since the first paper that described a primary-placement approach appeared in 1989, 16 additional papers have reported patient outcomes using both primary and delayed implant placements. None of these provide guidance over superiority. Nevertheless, in one paper within this category, which was not included in this systematic review, the authors had clear reservations about a primary placement approach when applied to maxillectomies. 1 The same group who described the primary placement protocol in the 1989 paper also reported in 1991 on 10 patients who had received implants placed at the time of ablative surgery. 2 This paper and the subsequent seven clinical studies referred to in the review do not present findings that raise major concerns about following a primary implant placement protocol.
The authors here identified three case reports and 13 reviews that offer opinions on this subject. It is obvious that this topic Results Three case reports, 13 reviews, and 25 clinical studies were selected. Eight of the clinical studies referred solely to the insertion of dental implants at the time of primary oncological resection, and only two were of a prospective design.
Conclusions Published studies concerning primary dental implants were concisely summarised, so that the collected evidence base surrounding this approach to oral rehabilitation could inform head and neck cancer teams, particularly oncological surgeons, restorative dentists, and maxillofacial prosthodontists. 
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and hyperbaric oxygen therapy are also arguments in favour of a primary placement protocol.
Weighted against these considerations are the potential adverse effects of the additional approx. 15% backscattering from titanium implants, and possible localised tissue damage if the patient needs to undergo radiotherapy. The exact limits and mechanisms of potential backscatter remain to be established, 5 and it has been claimed that the doses can be minimised to clinical insignificance by using multiple radiation fields. 6 Once again, the major concern is the dreaded osteonecrosis and its debilitating consequences, so that the precautionary principle tends to be applied. This is evidently not a new mindset. It is worth noting that a precautionary principle was also used in 1982 when titanium implants were first introduced.
The decree at the time was to avoid radiographs until the abutment connection stage in fear of disturbing the osseo-integration process. 7 Although this practice has been abandoned we are still
not confident about what is a maximum post-implant placement radiographic exposure.
A slightly different strategy to avoid possible detrimental additional backscatter generated during radiotherapy is the use of nonmetallic instead of titanium implants. At least one implant material, namely aluminium-oxide, appears in vitro to not generate any dose enhancements. 8 An additional consideration when weighing up the many rational arguments presented in older literature is that the technological developments of implant surfaces over the last 2 decades allow a more rapid osseo-integration today than the first generation of turned dental implants. Whereas previously the healing process was estimated to be about 16 weeks, the general consensus today is that 3-4 weeks suffice. 9 This timeframe is within the healing period following the ablative surgery, before commencing radiotherapy. 3, 4 A factor that deters decisions in favour of primary implant placement is the high risk of improper positioning if the surgery results in gross alteration of the maxilla-mandibular relationship. 10 Likely cancer therapy variables are the tumour region, the tumour stage, the malignancy aggressiveness, the radiotherapy planning target volume, fractionation schedules, and total radioactivity dose. Other variables with a probable, but unknown, impact are location and orientation of placed implants, bone continuity and maxilla-mandibular relationships. Finally, the skills and experience of the surgical team is an often overlooked variable when addressing outcomes of surgical interventions.
A concern is that the tumour recurrence in this patient population is high. 1, 4, 10, 11 Statistically, a large proportion of primary placed implants, if placed, will never be restored because of tumour recurrence, poor implant position, and patient health and function issues following resection and reconstruction. Competing for limited resources and surgery team priorities is an indisputable consideration. A cost-effectiveness/-utility appraisal of the resources utilisation versus patient quality of life may possibly provide these answers. 10, 11 First, however, the necessary clinical data foundation needs to be built.
A genuine obstacle to addressing risk and prognostic factors on outcomes following primary versus secondary implant placement is that clinical centres mostly work in isolation and, because of the low incidence of this type of surgery, are not able to establish statistical evidence. Extra-oral implants are more infrequent than intra-oral placements and the seven papers reporting on this application were excluded in this systematic review. Thus, it remains unknown whether the outcomes of extra-oral and intraoral implants are comparable, as a function of primary or secondary placement, with or without subsequent radiotherapy. With regard to both intra-and extra-oral implants, international cooperative efforts are needed to determine which patients may benefit from primary implant placement and where a delayed strategy seems the most advantageous.
Asbjørn Jokstad
University of Toronto, Faculty of Dentistry, Toronto, Canada
